Body aches and muscle pain are not among the most frequently reported side effects of Wegovy (semaglutide). Clinical trials have primarily identified gastrointestinal symptoms, including nausea, diarrhea, vomiting, and constipation, as the medication’s most common adverse reactions. According to the FDA prescribing information, muscle pain is not listed among adverse reactions occurring in at least 2% of patients receiving the 2.4 mg injectable dose at a higher rate than placebo. However, this does not mean that muscle discomfort cannot occur during treatment.
In today’s article, we would like to discuss the possibility of muscle aches and joint discomfort occurring after Wegovy therapy to lose weight. The blog post is great for both patients and specialists, so share it if you know someone who may find it helpful.
The exact percentage of Wegovy users who experience muscle aches remains unclear, as clinical trial data do not establish a specific incidence rate for this symptom. Some patients may develop muscle soreness indirectly due to dehydration, inadequate nutrient intake, changes in physical activity, or muscle loss during significant weight reduction. These factors can vary considerably between individuals, making it difficult to determine whether discomfort is directly related to the medication.
While occasional mild muscle aches may have several explanations, persistent or worsening pain should not be considered an expected part of Wegovy treatment. Patients experiencing unexplained muscle discomfort should consult their healthcare provider to identify the underlying cause and determine whether further evaluation is necessary.
Muscle pain experienced during Wegovy treatment may result from several interconnected factors rather than a direct effect of the medication itself. Although the underlying causes have not been clearly established, changes in body composition, hydration status, dietary habits, and exercise routines may contribute to muscle discomfort in some patients.
Fluid loss is taken seriously in the official labeling. Describing postmarketing reports of kidney injury, the prescribing information notes: “A majority of the reported events occurred in patients who had experienced nausea, vomiting, or diarrhea, leading to volume depletion” (Wegovy Prescribing Information, section 5.5 Acute Kidney Injury). The same dehydration that can damage the kidneys is a common, and much milder, cause of cramps and aches.
If you experience muscle pain while taking Wegovy, identifying the underlying cause is an important first step toward managing the discomfort. Although muscle pain is not among the medication’s most commonly reported side effects, different factors may contribute to muscle soreness. Several practical strategies can help support muscle health, relieve mild discomfort, and improve overall well-being throughout treatment. However, a healthcare professional should assess persistent or severe symptoms to rule out other potential causes.
Prioritize a balanced diet that provides adequate protein and essential vitamins and minerals to support muscle health and function. A registered dietitian can help develop an individualized nutrition plan, especially for patients with kidney and liver conditions that may require specific dietary adjustments.
Adequate hydration may help reduce muscle discomfort associated with dehydration, particularly in patients experiencing Wegovy-related nausea, vomiting, or diarrhea. The NHS advises most adults to consume 6-8 glasses of fluids daily, although this amount may need to be adjusted according to activity level, weather conditions, and individual health needs.
“the government recommends that people should aim to drink 6 to 8 cups or glasses of fluid a day” (NHS, Water, drinks and your health). The NHS adds that more may be needed when you are ill, physically active for long periods or in a hot environment.
People with heart or kidney disease should discuss their fluid requirements with a healthcare professional to avoid potential complications.
Incorporating gentle physical activity into your daily routine can help preserve muscle strength, improve flexibility, and support joint mobility while taking Wegovy. Low-impact exercises, including walking, swimming, stretching, and yoga, promote circulation and help reduce muscle stiffness without placing excessive strain on the body. Start with shorter, manageable sessions and gradually increase their duration and intensity based on your comfort level. Adding light resistance exercises may also help maintain muscle mass during weight loss. However, if you experience persistent or worsening muscle pain, avoid strenuous activity and consult your healthcare provider before continuing your exercise routine.
When starting Wegovy or increasing the dosage, giving your body sufficient time to adapt to the medication is essential. First, order Wegovy only from proven suppliers. Wegovy is typically introduced at a low dose and gradually increased over several months to improve tolerability and reduce gastrointestinal side effects. During this adjustment period, changes in appetite, reduced calorie intake, and potential dehydration may contribute to fatigue or muscle discomfort. Follow the prescribed dosing schedule and avoid increasing your dose without medical guidance. If side effects remain difficult to tolerate, your healthcare provider may recommend delaying a dose increase. Persistent, severe, or worsening muscle pain should be medically evaluated rather than assumed to be a normal part of adjusting to Wegovy.
Although Wegovy is generally well-tolerated, some patients may experience side effects as their bodies adjust to the medication. Gastrointestinal symptoms are the most commonly reported adverse reactions, while muscle aches, joint discomfort, and stiffness may also occur during treatment, although their direct connection to Wegovy remains unclear. Understanding the possible causes of these symptoms and knowing how to manage them can help patients maintain their comfort throughout the weight loss process. The following table outlines potential symptoms and practical management approaches, including when to seek medical attention.
| Side Effect | Management Options |
|---|---|
| Muscle aches or stiffness | Stay properly hydrated, incorporate light physical activity, and use paracetamol when appropriate to ease discomfort. |
| Pain or tenderness in the joints | Consider topical anti-inflammatory treatments for targeted relief. Avoid oral NSAIDs during dehydration or vomiting unless approved by a healthcare provider. |
| Muscle cramping associated with fluid or electrolyte loss | Replenish fluids regularly throughout the day and consult a healthcare professional if vomiting or diarrhea prevents adequate hydration. |
| Post-exercise muscle soreness (DOMS) | Introduce new exercises gradually, schedule sufficient rest between workouts, and practice gentle stretching to relieve tightness. |
| Intense or progressively worsening muscle or joint pain | Arrange a prompt medical assessment to identify the cause and determine whether changes to Wegovy treatment are necessary. |
| Persistent, severe abdominal pain extending toward the back | Obtain emergency medical care to rule out pancreatitis. Discontinue Wegovy if pancreatitis is suspected and do not restart unless instructed by a healthcare professional. |
| Upper-right abdominal pain with fever or yellowing of the skin or eyes | Seek immediate medical evaluation for possible gallbladder inflammation or other biliary complications. |
While mild muscle discomfort may improve with self-care, certain symptoms require medical evaluation. Contact your healthcare provider if you experience any of the following:
If body aches disrupt everyday activities or interfere with Wegovy treatment, consult your prescribing clinician to identify the cause and determine appropriate next steps.
Muscle pain and body aches are not among the most commonly reported side effects of Wegovy, but some patients may experience discomfort during treatment. Although a direct connection between semaglutide and muscle pain has not been clearly established, factors such as dehydration, inadequate nutrition, changes in body composition, and increased physical activity may contribute to these symptoms.
Maintaining proper hydration, consuming a balanced diet, staying physically active, and allowing sufficient time for dose adjustments can help support muscle health throughout treatment. However, persistent or worsening discomfort should not be dismissed as a normal response to Wegovy.
Muscle pain is not listed among the adverse reactions reported by at least 2% of adults on Wegovy 2.4 mg more often than placebo. The most common reactions are nausea, diarrhea, vomiting, constipation, abdominal pain, headache and fatigue. Aches during treatment are more often linked to dehydration, low protein intake, muscle loss or new exercise than to semaglutide itself.
Joint pain is not a recognised common side effect of Wegovy. Weight loss usually reduces the load on knees and hips, but changes in posture, activity and muscle mass can cause temporary soreness. Swollen, red or warm joints, or pain that keeps getting worse, need a medical review rather than self-treatment.
Leg cramps on Wegovy are most often linked to fluid and electrolyte loss from nausea, vomiting or diarrhea, especially after a dose increase. Eating much less can also lower intake of potassium and magnesium. Drinking regularly through the day and eating enough protein, vegetables and fruit usually helps; cramps with dizziness or very little urine need prompt advice.
Any substantial weight loss removes some lean tissue along with fat, and GLP-1 medicines are no exception. Getting enough protein at each meal and doing resistance exercise two or three times a week are the main ways to protect muscle while the scale goes down. A dietitian can help set a protein target for your body size.
See a doctor if aches are severe, keep worsening, or come with fever, marked weakness, dark urine, swelling of a joint, or signs of dehydration such as dizziness and little urine. Severe abdominal pain spreading to the back can signal pancreatitis, and upper-right abdominal pain with fever or yellow skin can signal gallbladder disease; both need urgent care.
Novo Nordisk. (2024). WEGOVY (semaglutide) injection, for subcutaneous use: Prescribing information. U.S. National Library of Medicine, DailyMed. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f5e548d0-cc79-4c34-a3f5-e20a5b8b6564
Wilding, J. P. H., Batterham, R. L., Calanna, S., et al. (2021). Once-weekly semaglutide in adults with overweight or obesity. The New England Journal of Medicine, 384(11), 989-1002. https://doi.org/10.1056/NEJMoa2032183
Conte, C., Hall, K. D., & Klein, S. (2024). Is weight loss-induced muscle mass loss clinically relevant? JAMA, 332(1), 9-10. https://doi.org/10.1001/jama.2024.6586
NHS. (n.d.). Water, drinks and your health. https://www.nhs.uk/live-well/eat-well/food-guidelines-and-food-labels/water-drinks-nutrition/
Get a 5% discount for the 1st order after registration
Create Account